Back
Bionano Genomics, Inc. 10K Form
Sell
20
BNGO
Bionano Genomics, Inc.
Last Price:
$1.70
Seasonality Move:
334.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNGO News And Ratings
See the #1 stock for the next 7 days that we like better than BNGO
BNGO Financial Statistics
Sales & Book Value
| Annual Sales: | $30.8M |
|---|---|
| Cash Flow: | $-5.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.12 |
| Price / Book: | 0.35 |
Profitability
| EPS (TTM): | -15.52560 |
|---|---|
| Net Income (TTM): | $-38.6M |
| Gross Margin: | $-10.7M |
| Return on Equity: | -84.77% |
| Return on Assets: | -48.54% |
Bionano Genomics, Inc. Earnings Forecast
Key Bionano Genomics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for BNGO is -34.72%.
-
The Selling, General & Administrative Expenses for BNGO have been equal to 168.49% of Gross Profit Margin.
-
The Research & Development expenses have been 80.59% of Revenue.
-
The Net Earning history of BNGO is -363.98% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Bionano Genomics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BNGO |
| CUSIP: | 09075F |
| Website: | bionano.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 2.12 |
| Quick Ratio: | 1.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNGO Technical Analysis vs Fundamental Analysis
Sell
20
Bionano Genomics, Inc. (BNGO)
is a Sell
Is Bionano Genomics, Inc. a Buy or a Sell?
-
Bionano Genomics, Inc. stock is rated a SellThe current Bionano Genomics, Inc. [BNGO] share price is $1.70. The Score for BNGO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.